Kennis Home Menselijke gezondheid Kennis All Advies Papieren Populaire wetenschap Interviews Filter Therapeutic areas COVID-19 Spijsverteringsgezondheid Apply Home Menselijke gezondheid Kennis Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate Home Menselijke gezondheid Kennis Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2 Home Menselijke gezondheid Kennis Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2 Home Menselijke gezondheid Kennis RBDCOV: The project’s origins and future endeavours Home Menselijke gezondheid Kennis RBDCOV Talks HIPRA’s participation: In 5 minutes, what is a recombinant protein vaccine? Home Menselijke gezondheid Kennis Humoral immune response against XBB.1.5 and BQ.1.1 SARS-CoV-2 variants of a fourth dose of PHH-1V vaccine in adult subjects Home Menselijke gezondheid Kennis Reactogenicity of third and fourth booster doses of HIPRA PHH-1V, a bivalent recombinant protein vaccine against SARS-CoV-2 Home Menselijke gezondheid Kennis Humoral immune response against SARS-CoV-2 variants of PHH-1V booster vaccine in subjects previously vaccinated with a mRNA vaccine Home Menselijke gezondheid Kennis One-year humoral response of PHH-1V booster vaccine in subjects previously vaccinated against COVID-19 with a mRNA vaccine Meer downloaden
